greeksoup/ stock research

American Healthcare REIT (AHR) FY2024 results: revenue $2.1 billion, up 10.9% on the year

American Healthcare REIT, Inc. (AHR) reported revenue of $2.1 billion for fiscal 2024, the year ended 31 December 2024, up 10.9% on the year before. Net income was -$38 million, and diluted earnings per share $-0.29. The figures are the company's own, from the 10-K it filed with the SEC on 27 February 2026.

Revenue
$2.1 billion
+10.9% on the year
FY2017FY2024
Operating margin
17.6%
16.4% a year earlier
FY2017FY2024
Net income
-$38 million
FY2017FY2024
Diluted EPS
-$0.29
FY2017FY2024

this yearthe year beforeHover a bar for its figure.

The year in brief

The four quarters: Q1 FY2024 · Q2 FY2024 · Q3 FY2024 · Q4 FY2024

Income statement (profit and loss)

$ millionFY2024FY2023FY2022On the yearLast 8 years
Revenue2,0711,8671,412+10.9%
Cost of revenue1,6541,5021,282+10.1%
Gross profit417364131+14.4%
Gross margin20.1%19.5%9.3%
Operating income364307302+18.5%
Operating margin17.6%16.4%21.4%
Interest expense128163106-21.7%
Pre-tax income-33.9-76.2-72.8
Income tax1.70.70.6+158.4%
Net income-37.8-71.5-81.3
Net margin-1.8%-3.8%-5.8%
Diluted EPS-$0.29-$1.08-$1.24
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2024FY2023FY2022On the yearLast 8 years
Operating cash flow17698.5148+78.7%
Capital expendituren/an/a7.5
Free cash flown/an/a140
Free cash flow marginn/an/a9.9%
Cash from investing-8.79.4-119
Cash from financing-135-129-42.9
Depreciation and amortisation179183168-1.9%
Share-based compensation9.95.53.9+80.5%
Buybacks0.00.520.7-97.0%
Dividends paid12176.351.1+58.5%
Dividend per share$1.00$1.00$1.600.0%
Diluted shares, weighted131m66m66m+97.8%

Balance sheet

$ millionFY2024FY2023FY2022On the yearLast 8 years
Shareholders' equity2,2611,2701,400+78.0%
Non-controlling interest42.7155168-72.4%
Debt1,6712,5262,512-33.9%
Other liabilities514626707-18.0%
Total liabilities and equity4,4884,5784,787-2.0%
Goodwill2353.3232+6,953.2%
Intangible assets161180236-10.5%
Securities held for sale or to maturity91.386.983.0+5.0%
Cash and equivalents76.743.465.1+76.5%
Inventory19.519.519.8+0.0%
Other assets3,9044,2444,151-8.0%
Total assets4,4884,5784,787-2.0%

10-K for the year ended 31 December 2024, filed 27 February 2026: the filing.